RE, P., EK, W., E, F., RW, H., GT, M., CA, N., . . . R, G. (2023). The Effect of In Utero Exposure to Maternal Inflammatory Bowel Disease and Immunomodulators on Infant Immune System Development and Function. Cellular and molecular gastroenterology and hepatology, 16(1), 165. https://doi.org/10.1016/j.jcmgh.2023.03.005
Chicago Style (17th ed.) CitationRE, Prentice, Wright EK, Flanagan E, Hunt RW, Moore GT, Nold-Petry CA, Bell SJ, Nold MF, and Goldberg R. "The Effect of In Utero Exposure to Maternal Inflammatory Bowel Disease and Immunomodulators on Infant Immune System Development and Function." Cellular and Molecular Gastroenterology and Hepatology 16, no. 1 (2023): 165. https://doi.org/10.1016/j.jcmgh.2023.03.005.
MLA (9th ed.) CitationRE, Prentice, et al. "The Effect of In Utero Exposure to Maternal Inflammatory Bowel Disease and Immunomodulators on Infant Immune System Development and Function." Cellular and Molecular Gastroenterology and Hepatology, vol. 16, no. 1, 2023, p. 165, https://doi.org/10.1016/j.jcmgh.2023.03.005.